Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evgenia Verrou

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Medicine|June 24, 2022
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to ControlsEleni Gavriilaki, Dimitra Dalampira, Foteini Theodorakakou, et al.
Hematological Oncology|August 6, 2024
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma groupEvgenia Verrou, Sotirios G Papageorgiou, Maria Bouzani, et al.
Blood Cancer Journal|March 11, 2018
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study GroupEirini Katodritou, Evangelos Terpos, Sossana Delimpasi, et al.
American Journal of Hematology|July 2, 2024
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study GroupEirini Katodritou, Dimitra Dalampira, Sosana Delimpasi, et al.
American Journal of Hematology|March 4, 2023
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study groupEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
American Journal of Hematology|April 24, 2014
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patientsEirini Katodritou, Evangelos Terpos, Argiris S Symeonidis, et al.
Annals of Hematology|October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experienceEirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
American Journal of Hematology|June 3, 2025
Characteristics and Survival Outcomes of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group on 175 PatientsEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
American Journal of Hematology|February 13, 2020
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working groupEirini Katodritou, Efstathios Kastritis, Moshe Gatt, et al.
In Vivo (Athens, Greece)|April 28, 2022
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell LymphomaStamatis J Karakatsanis, Maria Bouzani, Argyris Symeonidis, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Medicine|June 24, 2022
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to ControlsEleni Gavriilaki, Dimitra Dalampira, Foteini Theodorakakou, et al.
Hematological Oncology|August 6, 2024
Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma groupEvgenia Verrou, Sotirios G Papageorgiou, Maria Bouzani, et al.
Blood Cancer Journal|March 11, 2018
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study GroupEirini Katodritou, Evangelos Terpos, Sossana Delimpasi, et al.
American Journal of Hematology|July 2, 2024
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study GroupEirini Katodritou, Dimitra Dalampira, Sosana Delimpasi, et al.
American Journal of Hematology|March 4, 2023
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study groupEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
American Journal of Hematology|April 24, 2014
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patientsEirini Katodritou, Evangelos Terpos, Argiris S Symeonidis, et al.
Annals of Hematology|October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experienceEirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
American Journal of Hematology|June 3, 2025
Characteristics and Survival Outcomes of Solitary Plasmacytomas: A 30-Year Experience of the Greek Myeloma Study Group on 175 PatientsEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
American Journal of Hematology|February 13, 2020
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working groupEirini Katodritou, Efstathios Kastritis, Moshe Gatt, et al.
In Vivo (Athens, Greece)|April 28, 2022
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell LymphomaStamatis J Karakatsanis, Maria Bouzani, Argyris Symeonidis, et al.
Pageof 3